[go: up one dir, main page]

NO970910L - Spirostanylglykosidal-krystaller - Google Patents

Spirostanylglykosidal-krystaller

Info

Publication number
NO970910L
NO970910L NO970910A NO970910A NO970910L NO 970910 L NO970910 L NO 970910L NO 970910 A NO970910 A NO 970910A NO 970910 A NO970910 A NO 970910A NO 970910 L NO970910 L NO 970910L
Authority
NO
Norway
Prior art keywords
spirostanylglykosidal
crystals
spirostan
cellobiosyl
fluorophenylcarbamoyl
Prior art date
Application number
NO970910A
Other languages
English (en)
Other versions
NO970910D0 (no
Inventor
Douglas J Allen
Sr Richard A Buzon
Michael P Deninno
Jr Harry A Watson
Jonathan B Zung
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO970910D0 publication Critical patent/NO970910D0/no
Publication of NO970910L publication Critical patent/NO970910L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Høyt krystallinske former av (3(3, 5a, 25R)-3-[(p-D-4", 6"-bis[2-fluor- fenylkarbamoyl]cellobiosyl)oksy]-spirostan-12-on, som er anvendelige som hypokolesterolemisk eller anti-atherosklerosemiddel.
NO970910A 1994-08-30 1997-02-27 Spirostanylglykosidal-krystaller NO970910L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29810694A 1994-08-30 1994-08-30
PCT/IB1995/000317 WO1996006854A1 (en) 1994-08-30 1995-05-04 Spirostanyl glycosidal crystals

Publications (2)

Publication Number Publication Date
NO970910D0 NO970910D0 (no) 1997-02-27
NO970910L true NO970910L (no) 1997-02-27

Family

ID=23149057

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970910A NO970910L (no) 1994-08-30 1997-02-27 Spirostanylglykosidal-krystaller

Country Status (20)

Country Link
US (1) US5804562A (no)
EP (1) EP0778846A1 (no)
JP (1) JPH09510735A (no)
KR (1) KR970705574A (no)
AU (1) AU2265395A (no)
BR (1) BR9503827A (no)
CA (1) CA2198097A1 (no)
CO (1) CO4480032A1 (no)
FI (1) FI970828A7 (no)
HR (1) HRP950459A2 (no)
IL (1) IL115062A0 (no)
MA (1) MA23651A1 (no)
MX (1) MX9701525A (no)
NO (1) NO970910L (no)
OA (1) OA10402A (no)
PE (1) PE47696A1 (no)
PL (1) PL318937A1 (no)
SI (1) SI9520092A (no)
TR (1) TR199501065A2 (no)
WO (1) WO1996006854A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200002774T2 (tr) * 1998-03-26 2001-06-21 Phytopharm Plc Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9306619A (pt) * 1992-06-26 1998-12-08 Pfizer Glicosídeos esteroidais para o tratamento da hipercolesterolemia
AU7948494A (en) * 1993-12-28 1995-07-17 Pfizer Inc. Steroidal glycosides

Also Published As

Publication number Publication date
OA10402A (en) 2001-12-05
MX9701525A (es) 1997-05-31
AU2265395A (en) 1996-03-22
MA23651A1 (fr) 1996-04-01
TR199501065A2 (tr) 1996-06-21
IL115062A0 (en) 1995-12-08
FI970828A0 (fi) 1997-02-27
EP0778846A1 (en) 1997-06-18
HRP950459A2 (en) 1997-08-31
WO1996006854A1 (en) 1996-03-07
PL318937A1 (en) 1997-07-21
BR9503827A (pt) 1996-09-10
NO970910D0 (no) 1997-02-27
JPH09510735A (ja) 1997-10-28
CA2198097A1 (en) 1996-03-07
US5804562A (en) 1998-09-08
SI9520092A (en) 1997-12-31
FI970828L (fi) 1997-02-27
PE47696A1 (es) 1996-11-12
FI970828A7 (fi) 1997-02-27
KR970705574A (ko) 1997-10-09
CO4480032A1 (es) 1997-07-09

Similar Documents

Publication Publication Date Title
FI961506A0 (fi) Distamysiini A -analogit antituumorisina ja antiviraalisina aineina
NO912630L (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
FI960399A0 (fi) Perhydroisoindolijohdannaisia P-aineen antagonisteina
EP0667330A4 (no)
NO20001353L (no) Kondisjonerende sjampoblanding omfattende pentaerytritolesterolje
AU4387296A (en) Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and the use thereof as antiandrogens
PT97680A (pt) Processo para preparacao de novos compostos sulfonilo e de composicoes farmaceuticas que os contem
NO970910L (no) Spirostanylglykosidal-krystaller
NO954322L (no) Krystallins monohydrat av spirostanyl-glykosid
DK0730581T3 (da) 3-acylaminobezazepiner
AU548396B2 (en) 2-aryl-3,4-diazabicyclo(4.n.0)alk-2-en-5-ones
DK0746545T3 (da) Nipecotinsyrederivater som antithrombotiske forbindelser
DK0657106T3 (da) Hydrogenerede fructooligosaccharider
FI964045A0 (fi) CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä
NO981393L (no) Guanidinoproteasehemmere
NO912629L (no) Fremgangsmaate for fremstilling av nye bis(4-(2,6-dialkyl)fenol)silanderivater som antiarteriosklerotiske midler
AU562183B2 (en) 2-imino-pyrrolidines
EP0433855A3 (en) N- and o-substituted aminophenol derivatives, intermediates for their preparation, their use as hydrolase substrates, a corresponding assay and diagnostic agents
AU8798191A (en) Novel heptamethyl indane compound
CO4700429A1 (es) Un procedimiento para la preparacion de monohidrato de lora- carbef
MY109007A (en) Novel refrigerant composition.
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
CO4230100A1 (es) Procedimiento para convertir loracarbef dihidrato en loracarbef monohidrato
ES2134971T3 (es) Derivado de acido octahidro-2-naftaleno-carboxilico, su produccion y uso.